|
|
||||||||
1From the Department of Anatomy and Cell Biology and the 2Kresge Eye Institute, Wayne State University, Detroit, Michigan.
PURPOSE. To test the hypothesis that subnormal retinal oxygenation response (
PO2) found at 3 months of experimental diabetes is associated with cellular swelling and increased retinal thickness.
METHODS. Two groups of animals were studied: control rats injected intraperitoneally with either 15% body weight of saline or distilled water (cellular swelling model) or with intravitreal N-methyl-D-aspartate (NMDA) and 3-month-old diabetic and age-matched control rats. Intraocular pressure and retinal thickness was assessed using an applanation tonometer or high-resolution MRI (23.4 µm2 in-plane). In separate studies, functional MRI was used to measure blood-retinal barrier (BRB) integrity after Gd-DTPA injection intravenously and retinal
PO2 during carbogen provocation.
RESULTS. Inner and total retinal thickness were lower (P < 0.05) after NMDA injection, not different (P > 0.05) between control, before and after saline injection and before distilled water injection, and supernormal (P < 0.05) after distilled water injection. In diabetic rats, thickness was normal (P > 0.05) at most distances from the optic nerve but was subnormal (P < 0.05) in superior retina (0.5 mm from the optic nerve). Intraocular pressure was not different (P > 0.05) between groups. BRB was intact (P > 0.05) after saline and distilled water injection.
PO2 was normal (P > 0.05) after saline injection and over inferior hemiretina of the diabetic group but was subnormal (P < 0.05) after distilled water injection and over superior hemiretina of diabetic rats.
CONCLUSIONS. The lack of increased thickness in 3-month-old diabetic rats in vivo raises the possibility that intracellular swelling is unlikely to underlie subnormal
PO2 in experimental diabetes. In diabetic rats, the spatial disconnect between subnormal
PO2 pansuperiorly and retinal thinning only superiorly to the optic nerve suggests that neurovascular coupling is perturbed.
This article has been cited by other articles:
![]() |
B. A. Berkowitz, R. Roberts, J. S. Penn, and M. Gradianu High-Resolution Manganese-Enhanced MRI of Experimental Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4733 - 4740. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Berkowitz, R. Roberts, A. Stemmler, H. Luan, and M. Gradianu Impaired Apparent Ion Demand in Experimental Diabetic Retinopathy: Correction by Lipoic Acid Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4753 - 4758. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Berkowitz, R. Roberts, H. Luan, D. Bissig, B. V. Bui, M. Gradianu, D. J. Calkins, and A. J. Vingrys Manganese-Enhanced MRI Studies of Alterations of Intraretinal Ion Demand in Models of Ocular Injury Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3796 - 3804. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kim, C. J. Galban, R. J. Lutz, R. L. Dedrick, K. G. Csaky, M. J. Lizak, N. S. Wang, G. Tansey, and M. R. Robinson Assessment of Subconjunctival and Intrascleral Drug Delivery to the Posterior Segment Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 808 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Roberts, H. Luan, and B. A. Berkowitz {alpha}-Lipoic Acid Corrects Late-Phase Supernormal Retinal Oxygenation Response in Experimental Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4077 - 4082. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |